Emageon evaluating strategic optionsperhaps a sale?
Emageon, a provider of medical IT systems, has reported that it plans to evaluate its available strategic options, which could indicate a potential sale of the company.
To that end, the company has chosen Jefferies and Company, an investment bank and institutional securities firm, to act in a lead advisory capacity.
SunTrust Robinson Humphrey, which provides capital raising, strategic advisory, risk management and investment proposals, has been appointed to co-advise, according to the Birmingham, Ala.-based company.
Emageon lost $4.6 million in the first quarter of 2008 as revenue dropped 30 percent to $19.3 million, and also recently settled a proxy contest with New York City-based Oliver Press Partners, a major shareholder. The settlement has caused a shake-up within Emageon’s board of directors.
To that end, the company has chosen Jefferies and Company, an investment bank and institutional securities firm, to act in a lead advisory capacity.
SunTrust Robinson Humphrey, which provides capital raising, strategic advisory, risk management and investment proposals, has been appointed to co-advise, according to the Birmingham, Ala.-based company.
Emageon lost $4.6 million in the first quarter of 2008 as revenue dropped 30 percent to $19.3 million, and also recently settled a proxy contest with New York City-based Oliver Press Partners, a major shareholder. The settlement has caused a shake-up within Emageon’s board of directors.